Effects of COVID-19 on the R&D Investment of Pharmaceutical Industry in South Korea
Abstract
No Abstract. Not abstract.
1. Bachmann P, Frutos-Bencze, D (2022). R&D and inno-vation efforts during the COVID-19 pandemic: The role of universities. J Innovation Knowledge, 7(4): 100238.
2. Tortorice D, Rappuoli R, Bloom DE (2024). The eco-nomic case for scaling up health research and de-velopment: Lessons from the COVID-19 pandemic. Proce the National Acad Sci, 121(26): e2321978121.
3. Borino F, Carlson E, Rollo V, Solleder O (2024). Interna-tional firms and COVID-19: Evidence from a global survey. Rev World Eco: 1-34.
4. Zou Q, Wang Y, Modi S (2024). Linking government in-terventions to firm performance: the influence of stringency and support during the COVID-19 pan-demic. Int J Operations Production M, 44(2): 393-423.
2. Tortorice D, Rappuoli R, Bloom DE (2024). The eco-nomic case for scaling up health research and de-velopment: Lessons from the COVID-19 pandemic. Proce the National Acad Sci, 121(26): e2321978121.
3. Borino F, Carlson E, Rollo V, Solleder O (2024). Interna-tional firms and COVID-19: Evidence from a global survey. Rev World Eco: 1-34.
4. Zou Q, Wang Y, Modi S (2024). Linking government in-terventions to firm performance: the influence of stringency and support during the COVID-19 pan-demic. Int J Operations Production M, 44(2): 393-423.
| Files | ||
| Issue | Vol 54 No 2 (2025) | |
| Section | Letter to the Editor | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Yoon S. Effects of COVID-19 on the R&D Investment of Pharmaceutical Industry in South Korea. Iran J Public Health. 2025;54(2):447-449.
